In Vitro–In Vivo Correlation in Dermal Delivery: The Role of Excipients
The composition of topical and transdermal formulations is known to determine the rate and the extent of drug delivery to and through the skin. However, to date, the role of excipients in these formulations on skin delivery of actives has received little attention from scientists in the field. Monit...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-04-01
|
| Series: | Pharmaceutics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4923/13/4/542 |
| _version_ | 1797537894935560192 |
|---|---|
| author | Avnish Patel Fotis Iliopoulos Peter J. Caspers Gerwin J. Puppels Majella E. Lane |
| author_facet | Avnish Patel Fotis Iliopoulos Peter J. Caspers Gerwin J. Puppels Majella E. Lane |
| author_sort | Avnish Patel |
| collection | DOAJ |
| description | The composition of topical and transdermal formulations is known to determine the rate and the extent of drug delivery to and through the skin. However, to date, the role of excipients in these formulations on skin delivery of actives has received little attention from scientists in the field. Monitoring skin absorption of both drug and vehicle may provide insights into the mechanism by which excipients promote permeation and may facilitate the design of effective and safer products. Previously, we have investigated the use of quantitative Confocal Raman Spectroscopy (CRS) to investigate the delivery of an active to the skin, and we also reported the first fully quantitative study that compared this method with the well-established in vitro permeation test (IVPT) model. To further explore the potential of quantitative CRS in assessing topical delivery, the present work investigated the effects of commonly used excipients on the percutaneous absorption of a model drug, ibuprofen (IBU). Permeation of IBU and selected solvents following finite dose applications to human skin was determined in vitro and in vivo by Franz diffusion studies and quantitative CRS, respectively. The solvents used were propylene glycol (PG), dipropylene glycol (DPG), tripropylene glycol (TPG), and polyethylene glycol 300 (PEG 300). Overall, the cumulative amounts of IBU that permeated at 24 h in vitro were similar for PG, DPG, and TPG (<i>p</i> > 0.05). These three vehicles outperformed PEG 300 (<i>p</i> < 0.05) in terms of drug delivery. Concerning the vehicles, the rank order for in vitro skin permeation was DPG ≥ PG > TPG, while PEG 300 did not permeate the skin. A linear relationship between maximum vehicle and IBU flux in vitro was found, with a correlation coefficient (R<sup>2</sup>) of 0.95. When comparing in vitro with in vivo data, a positive in vitro–in vivo (IVIV) correlation between the cumulative permeation of IBU in vitro and the total amount of IBU that penetrated the stratum corneum (SC) in vivo was observed, with a Pearson correlation coefficient (R<sup>2</sup>) of 0.90. A strong IVIV correlation, R<sup>2</sup> = 0.82, was found following the linear regression of the cumulative number of solvents permeated in vitro and the corresponding skin uptake in vivo measured with CRS. This is the first study to correlate in vivo permeation of solvents measured by CRS with data obtained by in vitro diffusion studies. The IVIV correlations suggest that CRS is a powerful tool for profiling drug and vehicle delivery from dermal formulations. Future studies will examine additional excipients with varying physicochemical properties. Ultimately, these findings are expected to lead to new approaches for the design, evaluation, and optimization of formulations that target actives to and through the skin. |
| first_indexed | 2024-03-10T12:22:44Z |
| format | Article |
| id | doaj.art-f866b4957ce24cc196e41f830f0e66ce |
| institution | Directory Open Access Journal |
| issn | 1999-4923 |
| language | English |
| last_indexed | 2024-03-10T12:22:44Z |
| publishDate | 2021-04-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Pharmaceutics |
| spelling | doaj.art-f866b4957ce24cc196e41f830f0e66ce2023-11-21T15:21:15ZengMDPI AGPharmaceutics1999-49232021-04-0113454210.3390/pharmaceutics13040542In Vitro–In Vivo Correlation in Dermal Delivery: The Role of ExcipientsAvnish Patel0Fotis Iliopoulos1Peter J. Caspers2Gerwin J. Puppels3Majella E. Lane4Department of Pharmaceutics, UCL School of Pharmacy, 29-39 Brunswick Square, London WC1N 1AX, UKDepartment of Pharmaceutics, UCL School of Pharmacy, 29-39 Brunswick Square, London WC1N 1AX, UKRiverD International B.V., Marconistraat 16, 3029 AK Rotterdam, The NetherlandsRiverD International B.V., Marconistraat 16, 3029 AK Rotterdam, The NetherlandsDepartment of Pharmaceutics, UCL School of Pharmacy, 29-39 Brunswick Square, London WC1N 1AX, UKThe composition of topical and transdermal formulations is known to determine the rate and the extent of drug delivery to and through the skin. However, to date, the role of excipients in these formulations on skin delivery of actives has received little attention from scientists in the field. Monitoring skin absorption of both drug and vehicle may provide insights into the mechanism by which excipients promote permeation and may facilitate the design of effective and safer products. Previously, we have investigated the use of quantitative Confocal Raman Spectroscopy (CRS) to investigate the delivery of an active to the skin, and we also reported the first fully quantitative study that compared this method with the well-established in vitro permeation test (IVPT) model. To further explore the potential of quantitative CRS in assessing topical delivery, the present work investigated the effects of commonly used excipients on the percutaneous absorption of a model drug, ibuprofen (IBU). Permeation of IBU and selected solvents following finite dose applications to human skin was determined in vitro and in vivo by Franz diffusion studies and quantitative CRS, respectively. The solvents used were propylene glycol (PG), dipropylene glycol (DPG), tripropylene glycol (TPG), and polyethylene glycol 300 (PEG 300). Overall, the cumulative amounts of IBU that permeated at 24 h in vitro were similar for PG, DPG, and TPG (<i>p</i> > 0.05). These three vehicles outperformed PEG 300 (<i>p</i> < 0.05) in terms of drug delivery. Concerning the vehicles, the rank order for in vitro skin permeation was DPG ≥ PG > TPG, while PEG 300 did not permeate the skin. A linear relationship between maximum vehicle and IBU flux in vitro was found, with a correlation coefficient (R<sup>2</sup>) of 0.95. When comparing in vitro with in vivo data, a positive in vitro–in vivo (IVIV) correlation between the cumulative permeation of IBU in vitro and the total amount of IBU that penetrated the stratum corneum (SC) in vivo was observed, with a Pearson correlation coefficient (R<sup>2</sup>) of 0.90. A strong IVIV correlation, R<sup>2</sup> = 0.82, was found following the linear regression of the cumulative number of solvents permeated in vitro and the corresponding skin uptake in vivo measured with CRS. This is the first study to correlate in vivo permeation of solvents measured by CRS with data obtained by in vitro diffusion studies. The IVIV correlations suggest that CRS is a powerful tool for profiling drug and vehicle delivery from dermal formulations. Future studies will examine additional excipients with varying physicochemical properties. Ultimately, these findings are expected to lead to new approaches for the design, evaluation, and optimization of formulations that target actives to and through the skin.https://www.mdpi.com/1999-4923/13/4/542ibuprofenexcipientsskin deliveryConfocal Raman Spectroscopyin vitro–in vivo correlation |
| spellingShingle | Avnish Patel Fotis Iliopoulos Peter J. Caspers Gerwin J. Puppels Majella E. Lane In Vitro–In Vivo Correlation in Dermal Delivery: The Role of Excipients Pharmaceutics ibuprofen excipients skin delivery Confocal Raman Spectroscopy in vitro–in vivo correlation |
| title | In Vitro–In Vivo Correlation in Dermal Delivery: The Role of Excipients |
| title_full | In Vitro–In Vivo Correlation in Dermal Delivery: The Role of Excipients |
| title_fullStr | In Vitro–In Vivo Correlation in Dermal Delivery: The Role of Excipients |
| title_full_unstemmed | In Vitro–In Vivo Correlation in Dermal Delivery: The Role of Excipients |
| title_short | In Vitro–In Vivo Correlation in Dermal Delivery: The Role of Excipients |
| title_sort | in vitro in vivo correlation in dermal delivery the role of excipients |
| topic | ibuprofen excipients skin delivery Confocal Raman Spectroscopy in vitro–in vivo correlation |
| url | https://www.mdpi.com/1999-4923/13/4/542 |
| work_keys_str_mv | AT avnishpatel invitroinvivocorrelationindermaldeliverytheroleofexcipients AT fotisiliopoulos invitroinvivocorrelationindermaldeliverytheroleofexcipients AT peterjcaspers invitroinvivocorrelationindermaldeliverytheroleofexcipients AT gerwinjpuppels invitroinvivocorrelationindermaldeliverytheroleofexcipients AT majellaelane invitroinvivocorrelationindermaldeliverytheroleofexcipients |